Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort
Background: Mitochondrial DNA (mtDNA) copy number in peripheral blood has been found to be associated with risk of developing several cancers. However, data on pancreatic ductal adenocarcinoma (PDAC) are very limited. Methods: To further our knowledge on this topic, we measured relative mtDNA copy...
Главные авторы: | Gentiluomo, M, Katzke, V, Kaaks, R, Schmidt, J, Et al. |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
American Association for Cancer Research
2020
|
Схожие документы
-
Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
по: Daniele Campa, и др.
Опубликовано: (2018-04-01) -
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.
по: Hosnijeh, F, и др.
Опубликовано: (2014) -
Mitochondrial DNA copy number variation across human cancers
по: Ed Reznik, и др.
Опубликовано: (2016-02-01) -
Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study
по: Anika Hüsing, и др.
Опубликовано: (2020-03-01) -
Number of medically prescribed pharmaceutical agents as predictor of mortality risk: a longitudinal, time-variable analysis in the EPIC-Heidelberg cohort
по: Verena A. Katzke, и др.
Опубликовано: (2024-01-01)